As dig­i­tal health uni­corns are pres­sured to do more with less, Tran­scar­ent gets a fresh $126M

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.) 

Tran­scar­ent’s $126 mil­lion Se­ries D round, which in May bumped its val­u­a­tion to $2.2 bil­lion, stands apart from most growth-stage, high-val­u­a­tion star­tups that haven’t raised cap­i­tal in the past few years.

While many dig­i­tal health uni­corns have cut staff and shift­ed tac­tics to fo­cus on prof­it, not growth, Tran­scar­ent had $100 mil­lion in cash on hand go­ing in­to the round and plans to use the new mon­ey to grow its busi­ness, es­pe­cial­ly through ac­qui­si­tions, CEO Glen Tull­man told End­points News.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER